Back to search

Article

Molecular and Proteomic Profiles of Radioiodine Refractory Papillary Thyroid Cancer

2024-09-23

Abstract excerpt

<h4>Background</h4> Despite the generally favorable prognosis of papillary thyroid cancers (PTCs) following surgery with/without radioactive iodine (RAI) therapy, approximately one-third of patients experiencing recurrence and metastasis eventually develop resistance to RAI, leading to poor outcomes. However, the mechanisms underlying RAI-refractoriness remain elusive. This study aimed to assess the molecular and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f50819e9-19db-597d-8297-44580211a00b
DOI
10.1101/2024.09.22.24314143
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular and Proteomic Profiles of Radioiodine Refractory Papillary Thyroid CancerDOI 10.1101/2024.09.22.24314143
Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.Semantic proximity
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker InvestigationsSemantic proximity
TERT mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancerSemantic proximity
IGF2&nbsp;is a Potential Factor in RAI-refractory Non-medullary Thyroid CancerSemantic proximity
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networksSemantic proximity
Leveraging the transcriptome-phenotype relationship to guide clinical management of papillary thyroid cancer.Semantic proximity
Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risksSemantic proximity
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake.Semantic proximity
Update on the molecular diagnosis and targeted therapy of thyroid cancer.Semantic proximity
FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Semantic proximity
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid CancerSemantic proximity
The Role of the Kinase Inhibitors in Thyroid CancersSemantic proximity
Select a neighboring publication to make it the new centre.